TD Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.79M | Sell |
|
|||||
|
2025
Q1 | $8.47M | Sell |
|
|||||
|
2024
Q4 | $14.2M | Buy |
|
|||||
|
2024
Q3 | $10.7M | Buy |
|
|||||
|
2024
Q2 | $9.2M | Buy |
|
|||||
|
2024
Q1 | $10.3M | Sell |
|
|||||
|
2023
Q4 | $12.6M | Buy |
|
|||||
|
2023
Q3 | $11.4M | Buy |
|
|||||
|
2023
Q2 | $5.08M | Buy |
|
|||||
|
2023
Q1 | $1.44M | Hold |
|
|||||
|
2022
Q4 | $707K | Hold |
|
|||||
|
2022
Q3 | $538K | Buy |
|
|||||
|
2022
Q2 | $152K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $443K | Hold |
|
|||||
|
2021
Q3 | $442K | Hold |
|
|||||
|
2021
Q2 | $444K | Hold |
|
|||||
|
2021
Q1 | $458K | Hold |
|
|||||
|
2020
Q4 | $485K | Buy |
|